AdvaMed® Calls on Congress to Prevent Government Shutdown
Today, AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients:
Government & Legislative Affairs
Learn more about our Advocacy work.
New Episode of Medtech POV Podcast: Senator Richard Burr Discusses AI and Health Care, the VALID Act
Today, AdvaMed®, the Medtech Association, released the newest episode of Medtech POV with Scott Whitaker, featuring a conversation with former Senator Richard Burr of North Carolina.
Heart Surgeon, Small Medtech Company Leader Urges “Sensible” Sterilization Regulations, Cites Dire Consequences for Patients
In testimony today before the U.S. House of Representatives Committee on Small Business, Dr. Lishan Aklog urged Congress and the executive branch to consider the dire consequences for patients and…
AdvaMed® Announces New Chair of State Medtech Alliance
Today, AdvaMed®, the Medtech Association, announced Kelvyn Cullimore, President and CEO of BioUtah, will serve as the next chair of the State Medtech Alliance (SMTA). The Alliance is a consortium…
Automatic External Defibrillators (AEDs)
The on-field cardiac arrest of football player Damar Hamlin raised the profile of automatic external defibrillators (AEDs). An AED helped save his life.
AdvaMed® Statement on House Passage of Critical R&D Tax Provision
AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker upon the passage of a research and development expensing tax provision critical to medtech innovation in the…
AdvaMed® Urges Congress to Pass R&D Tax Provision Promoting, Preserving Medtech Innovation
Scott Whitaker, president and CEO of AdvaMed®, the Medtech Association, today urged Congress to enact a research and development expensing tax provision critical to medtech innovation. The provision would delay…
AdvaMed® 2024 State Policy Briefing: AI in Healthcare
AdvaMed® experts gave a presentation on how FDA regulates AI/ML in medical devices and how Medicare reimbursement policy is impacted by digital health technologies.
AdvaMed® 2024 State Policy Briefing: State Data Privacy Legislation
AdvaMed® held a panel discussion with partners at the International Pharmaceutical & Medical Device Privacy Consortium (IPMPC) on U.S. State Privacy Legislation.
ICYMI: AdvaMed® Calls for Greater Federal Prioritization of Medtech
In a new op-ed in RealClear Health, AdvaMed® President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…